Monitor for any future conversion to SC 13D if Tetragon engages with management, but current passive filing suggests no near-term activist intent. The call option component (1.5M shares underlying) adds modest upside exposure without current dilution.
Price Chart
Executive Summary
Tetragon Financial Group Limited and its affiliates disclosed a 5.2% passive stake in Silence Therapeutics plc via a new Schedule 13G filed October 13, 2026. The stake comprises 9,708,153 ordinary shares (represented by 3,236,051 ADSs), including 1,500,000 shares underlying call options. The filing confirms a passive investment intent with no control or influence purpose.
Key Financial Metrics
Key Facts
- Tetragon Financial Group Limited and affiliates hold 9,708,153 ordinary shares (5.2% of 186,461,401 shares outstanding).
- Stake is held via 3,236,051 ADSs, including 1,500,000 shares underlying call options exercisable into 500,000 ADSs.
- Filed as a new Schedule 13G under Rule 13d-1(c) — passive investment, no intent to influence control.
- Reporting persons include Tetragon Financial Management LP, Patrick G. G. Dear, and Reade E. Griffith.
- Date of event requiring filing: October 5, 2026.
Financial Impact
5.2% stake valued at approximately $[undisclosed] based on market price — no transaction price disclosed in filing.
Risk Factors
- Passive 13G could be converted to activist 13D if Tetragon changes intent, though no indication of this in filing.
- Call options represent contingent ownership — if exercised, would increase stake but no immediate dilution.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000919574-26-006888 |
| Document: 0000919574-26-006888-index-headers.html | 0000919574-26-006888 |
| Document: 0000919574-26-006888-index.html | 0000919574-26-006888 |
| Document: 0000919574-26-006888.txt | 0000919574-26-006888 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEFA14A | $19.61 $19.67 | ▲ +0.31% | ▼ −0.22% | $19.78 (+0.87%) |
Oct 19, 2026 7d ago | DEFA14A | $19.58 $19.61 | ▲ +0.15% | ▼ −0.18% | $19.78 (+1.02%) |
Oct 19, 2026 7d ago | 8-K | $19.58 $19.61 | ▲ +0.15% | ▼ −0.18% | $19.78 (+1.02%) |
Oct 13, 2026 13d ago | SC 13G/A | $8.98 $9.35 | ▲ +4.12% | ▲ +3.84% | $19.78 (+120.27%) |
Oct 13, 2026 13d ago | SC 13G | $8.98 $9.35 | ▲ +4.12% | ▲ +3.84% | $19.78 (+120.27%) |
Aug 10, 2026 11w ago | 424B5 | $14.72 $13.58 | ▲ +7.74% | ▲ +8.00% | $19.78 (−34.38%) |
Aug 10, 2026 11w ago | 8-K | $15.43 $14.72 | ▼ −4.60% | ▼ −4.28% | $19.78 (+28.19%) |
Aug 10, 2026 11w ago | 8-K | $15.43 $14.72 | ▼ −4.60% | ▼ −4.28% | $19.78 (+28.19%) |
Jun 23, 2026 17w ago | 8-K | $9.16 $10.00 | ▲ +9.17% | ▲ +9.03% | $19.78 (+115.94%) |
Mar 5, 2026 33w ago | 8-K | $5.50 $6.23 | ▲ +13.27% | ▲ +14.59% | $19.78 (+259.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers